IMVT - Immunovant - Stock Forecast IMVT is currently covered by 12 analysts with an average price target of $ This is a potential upside of $ . 22 analysts offering month price forecasts for Immunovant Inc (IMVT) have a share price target of $ This median of share price forecast represents a Immunovant Inc. analyst ratings, historical stock prices, earnings estimates & actuals. IMVT updated stock price target summary. Immunovant, Inc. (IMVT) stock forecast and price target · IMVTImmunovant, Inc. (%). At close: August 16 PM. Get the latest updates on Immunovant, Inc. Common Stock (IMVT) pre market trades, share volumes, and more. Make informed investments with Nasdaq.
Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends. Immunovant (NASDAQ:IMVT) Stock, Analyst Ratings, Price Targets, Forecasts. Immunovant Inc has a consensus price target of $ based on the ratings of According to analysts, IMVT price target is USD with a max estimate of USD and a min estimate of USD. Check if this forecast comes true in a. Immunovant stock price forecast: $; Market Cap: B, Enterprise value: B, P/E: , PEG ratio: , EPS: , Revenue: N/A, EBITDA: M. Is Immunovant Stock Undervalued? The current Immunovant [IMVT] share price is $ The Score for IMVT is 47, which is 6% below its historic median score of. Find the latest Immunovant, Inc. (IMVT) stock quote, history, news and other vital information to help you with your stock trading and investing. The Immunovant, Inc. stock price gained % on the last trading day (Friday, 23rd Aug ), rising from $ to $ During the last trading day the. Immunovant Inc Stock Price Forecast, "IMVT" Predictons for News · Immunovant (IMVT) Down % Since Last Earnings Report: Can It Rebound? Yahoo FinanceJun 28 ET · LifeSci Capital Maintains Immunovant(mgfoto.ru) With. On average, Wall Street analysts predict that Immunovant's share price could reach $ by Aug 13, The average Immunovant stock price prediction. Based on short-term price targets offered by 14 analysts, the average price target for Immunovant, Inc. comes to $ The forecasts range from a low of.
The average one-year price target for Immunovant, Inc. is $ The forecasts range from a low of $ to a high of $ A stock's price target is the. Analyst Price Targets Based on analysts offering 12 month price targets for IMVT in the last 3 months. The average price target is $ with a high estimate. On average, analysts forecast that IMVT's EPS will be -$ for , with the lowest EPS forecast at -$, and the highest EPS forecast at -$ In The average one-year price target for Immunovant, Inc. is $ The forecasts range from a low of $ to a high of $ A stock's price target is. Total Debt/Equity (mrq). %. Levered Free Cash Flow (ttm). M. View More. Research Analysis: IMVT. View More. Earnings Per Share. Consensus EPS. Analyst. Immunovant Stock Forecast, IMVT stock price prediction. Price target in 14 days: USD. The best long-term & short-term Immunovant share price. According to the 15 analysts' twelve-month price targets for Immunovant, the average price target is $ The highest price target for IMVT is $, while. The current price of IMVT is USD — it has increased by % in the past 24 hours. Watch Immunovant, Inc. stock price performance more closely on the. Immunovant Shares Skyrocket After Trial of Its Autoimmune Drug Beats Expectations. Immunovant (IMVT) shares virtually doubled on Tuesday after the.
(NASDAQ: IMVT) Immunovant stock price per share is $ today (as of Aug 19, ). What is Immunovant's Market Cap? View Immunovant Inc IMVT stock quote prices, financial information, real-time forecasts, and company news from CNN. Get the latest Immunovant (IMVT) stock forecast for tomorrow and next week. Stay ahead of the game with our Immunovant stock price prediction for and. Analyst Future Growth Forecasts Earnings vs Savings Rate: IMVT is forecast to remain unprofitable over the next 3 years. Earnings vs Market: IMVT is forecast. Immunovant Inc. analyst ratings, historical stock prices, earnings estimates & actuals. IMVT updated stock price target summary.
GET IN EARLY! Top 5 Stocks I'm Buying Before Nvidia Earnings (NVDA)
Analyst. Target Price. · 14 analysts ; Earnings. EPS Estimate. Due May 21 ; Investor. Trend. Sold. % shares. The stock price has increased by +% in the last 52 weeks. The beta is , so Immunovant's price volatility has been lower than the market average. Beta . View the real-time IMVT price chart on Robinhood and decide if you want to buy or sell commission-free. Other fees such as trading (non-commission) fees. Stock price target for Immunovant Inc IMVT are on downside and on upside. Stock price target for Immunovant Inc IMVT are on downside and